Related Experiment Video

Updated: Jun 24, 2025

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
08:04

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method

Published on: October 23, 2018

18.9K

Role of Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 Signaling in Liver and Metabolic Diseases

Felix Ampadu1, Vibhudutta Awasthi1, Aditya D Joshi2

  • 1Department of Pharmaceutical Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.

The Journal of Pharmacology and Experimental Therapeutics
|June 6, 2024
PubMed

Insights

Mitogen-activated protein kinase kinase kinase 4 (MAP4K4) is increasingly linked to liver and metabolic diseases. Targeting MAP4K4 offers a promising therapeutic strategy for these conditions.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Pathophysiology

Background:

  • Mitogen-activated protein kinase kinase kinase 4 (MAP4K4) is a serine/threonine protein kinase implicated in various biological processes and diseases.
  • Recent evidence highlights MAP4K4's upregulation in hyperglycemia and liver diseases, suggesting a critical role in metabolic dysfunction.

Purpose of the Study:

  • To review the current understanding of MAP4K4 structure, expression, regulation, and signaling pathways.
  • To focus on MAP4K4's specific role in metabolic and hepatic diseases.
  • To identify MAP4K4 as a potential therapeutic target for liver and metabolic disorders.

Main Methods:

  • Literature review of recent studies on MAP4K4.
  • Analysis of MAP4K4 expression and signaling in the context of metabolic diseases.
  • Synthesis of information regarding MAP4K4's involvement in hyperglycemia and liver pathologies.

Main Results:

  • MAP4K4 plays a significant role in regulating biological processes relevant to metabolic health.
  • MAP4K4 expression and signaling are elevated in conditions like hyperglycemia and liver disease.
  • MAP4K4 is emerging as a key player in the pathophysiology of metabolic and hepatic diseases.

Conclusions:

  • Understanding MAP4K4 signaling pathways is crucial for developing new therapeutic strategies.
  • MAP4K4 represents a clinically relevant target for innovative interventions against liver and metabolic diseases.

More Related Videos

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

15.9K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:39

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

73

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.4K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.3K